AS

Adarsh Shaw

Active Director Director DIN 08730622
DIN 08730622 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Adarsh Shaw

Data last updated:

Adarsh Shaw is a Director at Arti Medical Research Foundation (since 2022). The company operates in Healthcare. Arti Medical Research Foundation reported revenue of ₹32.43 Cr (FY 2025).

DIN 08730622
Primary Designation Director
Industry Healthcare
First Appointment 30 Sep 2022
Oldest Company Age 14 yrs
Largest company Arti Medical Research Foundation · ₹32.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arti Medical Research Foundation U85300WB2012NPL180138
Director30 Sep 20222012₹32.43 Cr (FY 2025)Active

Board colleagues of Adarsh Shaw

Directorship timeline

Open interactive timeline →
Arti Medical Research Foundation
Premium access

Shareholding and investment profile for Adarsh Shaw

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adarsh Shaw

Adarsh Shaw currently holds 1 directorship: Arti Medical Research Foundation (Director, since 30 Sep 2022, revenue ₹32.43 Cr (FY 2025)).

Adarsh Shaw was first appointed on 30 Sep 2022 as Director at Arti Medical Research Foundation.

The current boards of Adarsh Shaw's companies include Ajay Kumar Shaw (Arti Medical Research Foundation), Anushka Shaw (Arti Medical Research Foundation), Arati Shaw (Arti Medical Research Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available